Daniel V. Catenacci, MD, University of Chicago
Advertisement
Articles by Daniel V. Catenacci, MD, University of Chicago
Advertisement
Latest Updated Articles
Global Use of Frontline Therapy in Metastatic Gastric CancerPublished: June 2nd 2020 | Updated:
ESMO 2020: Practice-Changing Data in Esophageal CancerPublished: October 22nd 2020 | Updated:
First-Line I/O Successful in Gastric AdenocarcinomaPublished: October 22nd 2020 | Updated:
Perioperative Strategies in Metastatic Gastric CancerPublished: June 2nd 2020 | Updated:
Predicting Response With Biomarkers in Gastric CancersPublished: October 22nd 2020 | Updated:
Optimal Approach Toward Advanced Gastric Cancers in USPublished: October 22nd 2020 | Updated:
Advertisement
Advertisement
Trending on OncLive
1
Long-Term Cilta-Cel Data Show Low Rates of PFS Events in Standard-Risk R/R Myeloma
2
FDA Updates Axi-Cel Label to Remove Limitation of Use in R/R PCNSL
3
Real-World Data Support Clinical Benefit With Lifileucel in Previously Treated Advanced Melanoma
4
Nonresponse to Bridging Therapy and Peak ALC After Cilta-Cel Are Associated With Neurotoxicity, NRM in Myeloma
5